Electrotherapies in Medicine Group (GEM)
GEM (Grupo de Electroterapias en Medicina) is an Argentine medical organization dedicated to offering electrochemotherapy as an effective, minimally invasive and innovative option for skin cancer, cutaneous tumors and other tissue-level conditions.
With a recognized scientific track record and results comparable to leading European centers, we support patients, physicians and institutions in implementing this technique safely.
Scientific research and medical practice
We are an Argentine organization dedicated to the development, study and clinical implementation of electroporation-based cancer therapies, with a special focus on electrochemotherapy.
Born where scientific research meets medical practice, GEM brings patients advanced, effective and internationally validated treatments for skin cancer and other tumors.
Mission and purpose
As a leading institution in Latin America, our goal is to bring biomedical innovation into clinical practice with safe, precise and evidence-based therapeutic options. We work with patients, referring physicians, clinics, hospitals and insurers to add electroporation technologies to the treatment options available.
What we offer
GEM combines clinical care, research, teaching and technology transfer:
- Assessment of referred patients and support through treatment and follow-up.
- Institutional implementation of electrochemotherapy as a complementary or second-line therapy.
- Medical training and technical support for professionals and institutions adopting the procedure.
- Scientific and technological advice for adopting ANMAT-approved equipment.
- Scientific output through publications, conferences and national and international partnerships.
Dr. Felipe Maglietti
GEM brings together physicians, researchers, engineers and professionals from several fields, led by Dr. Felipe Maglietti, physician with a Doctorate in Medicine summa cum laude, researcher at CONICET (Argentina's National Scientific and Technical Research Council) and director of the Barceló Institute for Translational Research (InBIT).
His pioneering work made Argentina the first country in Latin America to adopt electrochemotherapy as a standard treatment, establishing a model of medical innovation with a direct impact on patients' quality of life.
Professionals from many disciplines
Specialists in electroporation, plastic surgery, dermatology, gynecology, anesthesiology, nutrition and other key medical fields. This combined expertise lets us approach each case with a complete, rigorous view focused on the best clinical response.
Our principles
Mission
To promote the development, research and clinical implementation of therapies that bring innovation into medical practice and improve patients' quality of life.
Vision
To be the Latin American reference in electroporation-based therapies, fostering collaboration among medical institutions, research centers and public and private organizations.
Values
- Innovation
- Applied science
- Medical ethics
- Continuing education
- Social impact
Endorsements and certifications
Dr. Felipe Maglietti is internationally recognized for his contribution to electroporation-based therapies. His awards include the Justin Teissié Award from the International Society for Electroporation-Based Technologies and Treatments (ISEBTT) and the Instituto Balseiro award for the project with the greatest social impact.
He is also the inventor of a patented device for treating deep tumors with electroporation technologies.
Do you have a question?
We are available to assess your case, train you or advise your institution.